Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of Candida bloodstream isolates. results from a six-year study (1996

Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of Candida bloodstream isolates. results from a six-year study (1996–2001)

Published:2003-08 Issue:4 Volume:46 Page:259-264
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Marco F.,Danés C.,Almela M.,Jurado A.,Mensa J.,de la Bellacasa J.Puig,Espasa M.,Martínez J.A.,Jiménez de Anta M.T.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference24 articles.

1. The epidemiology of hematogeneous candidiasis caused by different Candida species;Abi-Said;Clin Infect Dis,1997

2. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review;Anaissie;Clin Infect Dis,1992

3. Phase I dose optimization study for V-echinocandin (Abstr 1105). Programs and Abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 2000;Brown,2000

4. Epidemiology of nosocomial fungal infections;Fridkin;Clin Microbiol Rev,1996

5. Itraconazole oral solutions for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia;Harousseau;Antimicrob Agents Chemother,2000

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis and Treatment Challenges of Candida guilliermondii in Immunocompromised Patients: A Case Study in a Neutropenic AML Patient;Case Reports in Infectious Diseases;2024-01

Current Aspects in the Biology, Pathogeny, and Treatment of Candida krusei, a Neglected Fungal Pathogen

;Infection and Drug Resistance;2020-06

3. Candida parapsilosis: from Genes to the Bedside;Clinical Microbiology Reviews;2019-03-20

4. D-Cateslytin: a new antifungal agent for the treatment of oral Candida albicans associated infections;Scientific Reports;2018-06-18

5. Epidemiology of candidaemia in a tertiary care university hospital: 10-year experience with 381 candidaemia episodes between 2001 and 2010;Mycoses;2015-07-07